FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016121352> ?p ?o ?g. }

• W2016121352 endingPage "532" @default.
• W2016121352 startingPage "530" @default.
• W2016121352 abstract "Background Studies of the suppressive effect of H1-receptor antagonists on the histamine-induced wheal and flare are useful for assessing peripheral H1-blockade. Objective To compare the peripheral H1-blockade produced by fexofenadine, 60 mg twice daily or 120 mg once daily; loratadine, 10 mg once daily; and placebo during 24 hours. Methods In this randomized, double-blind, single-dose, crossover study in 20 subjects, the wheals and flares produced by epicutaneous tests with histamine phosphate 1 mg/mL were measured before and at intervals (20, 40, 60 minutes, hourly until 12 hours, and 24 hours) after the ingestion of fexofenadine, 60 mg twice daily; fexofenadine, 120 mg once daily; loratadine, 10 mg once daily; or placebo. Results All active medications effectively suppressed the histamine-induced wheal and flare for 24 hours compared with placebo. Fexofenadine 60 mg twice daily and fexofenadine 120 mg once daily had a faster onset of action than loratadine in this experimental model. Conclusions Peripheral H1-blockade studies are useful for investigation of the differences among H1-receptor antagonists. They complement large clinical trials in which efficacy is subjectively assessed using symptom scores, and which are more likely to demonstrate similarities among the different medications in this class, and among different doses of the same H1-receptor antagonist. Studies of the suppressive effect of H1-receptor antagonists on the histamine-induced wheal and flare are useful for assessing peripheral H1-blockade. To compare the peripheral H1-blockade produced by fexofenadine, 60 mg twice daily or 120 mg once daily; loratadine, 10 mg once daily; and placebo during 24 hours. In this randomized, double-blind, single-dose, crossover study in 20 subjects, the wheals and flares produced by epicutaneous tests with histamine phosphate 1 mg/mL were measured before and at intervals (20, 40, 60 minutes, hourly until 12 hours, and 24 hours) after the ingestion of fexofenadine, 60 mg twice daily; fexofenadine, 120 mg once daily; loratadine, 10 mg once daily; or placebo. All active medications effectively suppressed the histamine-induced wheal and flare for 24 hours compared with placebo. Fexofenadine 60 mg twice daily and fexofenadine 120 mg once daily had a faster onset of action than loratadine in this experimental model. Peripheral H1-blockade studies are useful for investigation of the differences among H1-receptor antagonists. They complement large clinical trials in which efficacy is subjectively assessed using symptom scores, and which are more likely to demonstrate similarities among the different medications in this class, and among different doses of the same H1-receptor antagonist." @default.
• W2016121352 created "2016-06-24" @default.
• W2016121352 creator A5070020110 @default.
• W2016121352 creator A5087600572 @default.
• W2016121352 date "1997-12-01" @default.
• W2016121352 modified "2023-09-28" @default.
• W2016121352 title "Peripheral H1-Blockade Effect of Fexofenadine" @default.
• W2016121352 cites W1982550010 @default.
• W2016121352 cites W1991790975 @default.
• W2016121352 cites W2022267899 @default.
• W2016121352 cites W2023671946 @default.
• W2016121352 cites W2025928937 @default.
• W2016121352 cites W2313064083 @default.
• W2016121352 doi "https://doi.org/10.1016/s1081-1206(10)63061-x" @default.
• W2016121352 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9433369" @default.
• W2016121352 hasPublicationYear "1997" @default.
• W2016121352 type Work @default.
• W2016121352 sameAs 2016121352 @default.
• W2016121352 citedByCount "50" @default.
• W2016121352 countsByYear W20161213522015 @default.
• W2016121352 countsByYear W20161213522018 @default.
• W2016121352 countsByYear W20161213522019 @default.
• W2016121352 crossrefType "journal-article" @default.
• W2016121352 hasAuthorship W2016121352A5070020110 @default.
• W2016121352 hasAuthorship W2016121352A5087600572 @default.
• W2016121352 hasConcept C10335311 @default.
• W2016121352 hasConcept C1122143 @default.
• W2016121352 hasConcept C126322002 @default.
• W2016121352 hasConcept C142724271 @default.
• W2016121352 hasConcept C170493617 @default.
• W2016121352 hasConcept C204787440 @default.
• W2016121352 hasConcept C27081682 @default.
• W2016121352 hasConcept C2776711289 @default.
• W2016121352 hasConcept C2776880894 @default.
• W2016121352 hasConcept C2776885963 @default.
• W2016121352 hasConcept C2778468042 @default.
• W2016121352 hasConcept C2779303165 @default.
• W2016121352 hasConcept C2779463773 @default.
• W2016121352 hasConcept C2780734495 @default.
• W2016121352 hasConcept C42219234 @default.
• W2016121352 hasConcept C71924100 @default.
• W2016121352 hasConcept C87813604 @default.
• W2016121352 hasConcept C98274493 @default.
• W2016121352 hasConceptScore W2016121352C10335311 @default.
• W2016121352 hasConceptScore W2016121352C1122143 @default.
• W2016121352 hasConceptScore W2016121352C126322002 @default.
• W2016121352 hasConceptScore W2016121352C142724271 @default.
• W2016121352 hasConceptScore W2016121352C170493617 @default.
• W2016121352 hasConceptScore W2016121352C204787440 @default.
• W2016121352 hasConceptScore W2016121352C27081682 @default.
• W2016121352 hasConceptScore W2016121352C2776711289 @default.
• W2016121352 hasConceptScore W2016121352C2776880894 @default.
• W2016121352 hasConceptScore W2016121352C2776885963 @default.
• W2016121352 hasConceptScore W2016121352C2778468042 @default.
• W2016121352 hasConceptScore W2016121352C2779303165 @default.
• W2016121352 hasConceptScore W2016121352C2779463773 @default.
• W2016121352 hasConceptScore W2016121352C2780734495 @default.
• W2016121352 hasConceptScore W2016121352C42219234 @default.
• W2016121352 hasConceptScore W2016121352C71924100 @default.
• W2016121352 hasConceptScore W2016121352C87813604 @default.
• W2016121352 hasConceptScore W2016121352C98274493 @default.
• W2016121352 hasIssue "6" @default.
• W2016121352 hasLocation W20161213521 @default.
• W2016121352 hasLocation W20161213522 @default.
• W2016121352 hasOpenAccess W2016121352 @default.
• W2016121352 hasPrimaryLocation W20161213521 @default.
• W2016121352 hasRelatedWork W141509808 @default.
• W2016121352 hasRelatedWork W1967541102 @default.
• W2016121352 hasRelatedWork W2017479925 @default.
• W2016121352 hasRelatedWork W2038382554 @default.
• W2016121352 hasRelatedWork W2129867925 @default.
• W2016121352 hasRelatedWork W47817786 @default.
• W2016121352 hasRelatedWork W74436779 @default.
• W2016121352 hasRelatedWork W1759177440 @default.
• W2016121352 hasRelatedWork W2048904776 @default.
• W2016121352 hasRelatedWork W2183184563 @default.
• W2016121352 hasVolume "79" @default.
• W2016121352 isParatext "false" @default.
• W2016121352 isRetracted "false" @default.
• W2016121352 magId "2016121352" @default.
• W2016121352 workType "article" @default.